Pihlajalinna Oyj (LSE:0R8H) - Stock Price, News & Analysis

0R8H Stock Overview

Pihlajalinna Oyj provides social, healthcare, and wellbeing services in Finland.

0R8H fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	3/6
Past Performance	1/6
Financial Health	1/6
Dividends	0/6

Rewards

Trading at 62.5% below our estimate of its fair value

Earnings are forecast to grow 26.43% per year

Risk Analysis

Shares are highly illiquid

Interest payments are not well covered by earnings

Profit margins (0.8%) are lower than last year (1.4%)

Large one-off items impacting financial results

Pihlajalinna Oyj Competitors

Integrated Diagnostics Holdings

LSE:IDHC

US$210.0m

PHSC

AIM:PHSC

UK£2.3m

Tristel

AIM:TSTL

UK£211.5m

Instem

AIM:INS

UK£199.6m

Price History & Performance

Summary of all time highs, changes and price drops for Pihlajalinna Oyj
Historical stock prices
Current Share Price	€7.56
52 Week High	€9.90
52 Week Low	€6.89
Beta	0.38
1 Month Change	0%
3 Month Change	8.93%
1 Year Change	-12.10%
3 Year Change	-33.92%
5 Year Change	-29.02%
Change since IPO	-41.40%

Recent updates

Shareholder Returns

	0R8H	GB Healthcare	GB Market
7D	0%	1.3%	-0.7%
1Y	-12.1%	-28.0%	-1.8%

Return vs Industry: 0R8H exceeded the UK Healthcare industry which returned -28.3% over the past year.

Return vs Market: 0R8H underperformed the UK Market which returned -2.4% over the past year.

Price Volatility

Is 0R8H's price volatile compared to industry and market?
0R8H volatility
0R8H Average Weekly Movement	n/a
Healthcare Industry Average Movement	7.4%
Market Average Movement	4.8%
10% most volatile stocks in GB Market	11.5%
10% least volatile stocks in GB Market	2.6%

Stable Share Price: 0R8H has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine 0R8H's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2014	6,880	Tuomas Hyyrylainen	www.pihlajalinna.fi

Pihlajalinna Oyj provides social, healthcare, and wellbeing services in Finland. It offers general practitioner and medical specialist, occupational healthcare, social and healthcare outsourcing, fitness center, responsible doctor, and remote consultation services, as well as residential and staffing services. The company also provides dental care, diagnostics, and rehabilitation services.

Pihlajalinna Oyj Fundamentals Summary

How do Pihlajalinna Oyj's earnings and revenue compare to its market cap?
0R8H fundamental statistics
Market cap	€180.42m
Earnings (TTM)	€5.73m
Revenue (TTM)	€720.52m

31.5x

P/E Ratio

0.3x

P/S Ratio

Is 0R8H overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0R8H income statement (TTM)
Revenue	€720.52m
Cost of Revenue	€577.99m
Gross Profit	€142.53m
Other Expenses	€136.80m
Earnings	€5.73m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 03, 2024

Earnings per share (EPS)	0.25
Gross Margin	19.78%
Net Profit Margin	0.80%
Debt/Equity Ratio	101.6%

How did 0R8H perform over the long term?

See historical performance and comparison

Dividends

0.9%

Current Dividend Yield

28%

Payout Ratio

0R8H Stock Overview

Rewards

Risk Analysis

Pihlajalinna Oyj Competitors

LSE:IDHC

US$210.0m

AIM:PHSC

UK£2.3m

AIM:TSTL

UK£211.5m

AIM:INS

UK£199.6m

Price History & Performance

Recent News & Updates

Pihlajalinna plc announces Changes in Management Team

Pihlajalinna plc Announces Board Committee Appointments

Pihlajalinna Oyj (HLSE:PIHLIS) announces an Equity Buyback for 150,000 shares, representing 0.66% for €1.3 million.

Pihlajalinna Oyj (HLSE:PIHLIS) announces an Equity Buyback for 150,000 shares, representing 0.66% for €1.3 million.

Pihlajalinna Oyj Proposes Dividend for Financial Year That Ended on 31 December 2023, Payable on 19 April 2024

Antti-Jussi Aro Decides to Leave Pihlajalinna plc as Chief Information Officer, Effective 10 May 2024

Recent updates

Pihlajalinna plc announces Changes in Management Team

Pihlajalinna plc Announces Board Committee Appointments

Pihlajalinna Oyj (HLSE:PIHLIS) announces an Equity Buyback for 150,000 shares, representing 0.66% for €1.3 million.

Pihlajalinna Oyj (HLSE:PIHLIS) announces an Equity Buyback for 150,000 shares, representing 0.66% for €1.3 million.

Pihlajalinna Oyj Proposes Dividend for Financial Year That Ended on 31 December 2023, Payable on 19 April 2024

Antti-Jussi Aro Decides to Leave Pihlajalinna plc as Chief Information Officer, Effective 10 May 2024

Pihlajalinna Oyj Proposes Dividend for the Financial Year That Ended on 31 December 2023

Pihlajalinna plc Announces Resignation of Timo Harju as Chief Operating Officer, Private Health Services, Effective 29 February 2024

Pihlajalinna Plc Provides Earnings Guidance for the Year 2023

New minor risk - Earnings quality

Third quarter 2023 earnings released: EPS: €0.13 (vs €0.15 in 3Q 2022)

Pihlajalinna Oyj Reaffirms Revenue Guidance for 2023

Pihlajalinna Oyj to Report Fiscal Year 2023 Results on Feb 14, 2024

Second quarter 2023 earnings released: EPS: €0.089 (vs €0.075 in 2Q 2022)

Pihlajalinna Oyj Provides Revenue Guidance for the Year 2023

Pihlajalinna Announces Appointment of Tuomas Hyyryläinen as the CEO, Effective 1 September 2023

Independent Vice Chair of the Board recently bought €271k worth of stock

First quarter 2023 earnings released: EPS: €0.24 (vs €0.23 in 1Q 2022)

Full year 2022 earnings released: EPS: €0.42 (vs €0.89 in FY 2021)

Pihlajalinna Oyj Provides Earnings Guidance for the Year 2023

Hammas Hohde Oy entered into an agreement acquire Oral health business of Pihalajalinna.

Hammas Hohde Oy entered into an agreement acquire Oral health business of Pihalajalinna.

Pihlajalinna Oyj Provides Earnings Guidance for the Year 2022

Third quarter 2022 earnings released: EPS: €0.14 (vs €0.30 in 3Q 2021)

Pihlajalinna Oyj Provides Earnings Guidance for Full Year 2022

Pihlajalinna Oyj to Report Q1, 2023 Results on Apr 28, 2023

Pihlajalinna Oyj Announces Changes in Management Team

Second quarter 2022 earnings released: EPS: €0.08 (vs €0.20 in 2Q 2021)

Pihlajalinna Oyj Reiterates Earnings Guidance for the Year 2022

Pihlajalinna Ordinary Shares to Be Deleted from Other OTC

Kati Sulin to Resign from the Board of Directors of Pihlajalinna Plc

Insufficient new directors

First quarter 2022 earnings released: EPS: €0.23 (vs €0.20 in 1Q 2021)

Pihlajalinna plc Appoints Eetu Salunen as New Head of Business Operations, Effective from 1 August 2022

Insufficient new directors

Pihlajalinna Oyj Approves Dividend, Payable on 26 April 2022

Upcoming dividend of €0.30 per share

Investor sentiment improved over the past week

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Pihlajalinna Oyj Provides Earnings Guidance for the Year 2022

Third quarter 2021 earnings released: EPS €0.31 (vs €0.20 in 3Q 2020)

Second quarter 2021 earnings released: EPS €0.20 (vs €0.027 loss in 2Q 2020)

Pihlajalinna Oyj (HLSE:PIHLIS) entered into an agreement to acquire Digital Health Solutions.

First quarter 2021 earnings released: EPS €0.20 (vs €0.057 in 1Q 2020)

Pihlajalinna Oyj Provides Earnings Guidance for the Year 2021

Independent Director has left the company

Upcoming dividend of €0.20 per share

Full year 2020 earnings released: EPS €0.39 (vs €0.15 in FY 2019)

Pihlajalinna Oyj Announces Sanna Määttänen Has Resigned as Chief Business Development Officer and Chief Information Officer

Pihlajalinna Oyj Proposes Dividend for the Fiscal Year Ended December 31, 2020, Payable on 26 April 2021

Revenue beats expectations

Full year 2020 earnings released: EPS €0.39 (vs €0.15 in FY 2019)

Pihlajalinna Announces That Matti Jaakola Will No Longer Be A Member of the Board

Pihlajalinna Oyj Appoints Sari Riihijärvi as Medical Director, Effective on 2 July 2021

Shareholder Returns

Price Volatility

About the Company

Pihlajalinna Oyj Fundamentals Summary

31.5x